title: The androgen receptor, androgen synthesis, and new designer antiandrogens for metastatic castration-resistant prostate cancer: teaching old dogs new tricks.
authors: Ronald
authors: R
authors: Lieberman
mesh_terms: D000069501:Abiraterone Acetate; D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000730:Androstadienes / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009570:Nitriles; D009919:Orchiectomy; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D011944:Receptors, Androgen / Q000187:drug effects / Q000378:metabolism; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000726:Androgen Antagonists; D000730:Androstadienes; D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D011944:Receptors, Androgen; D010669:Phenylthiohydantoin; C540278:enzalutamide; D000069501:Abiraterone Acetate